H.C. Wainwright Upgrades Dicerna Pharmaceuticals (DRNA) to Buy
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/8/2026
- Fiserv president resigns, interim leaders named for financial unit
- Nasdaq sinks as AI worries hit chipmakers
- Amazon launches bond sale seeking at least $25 billion
- Raymond James Starts SpaceX (SPCX) at Strong Buy, PT Street High $800
- Exclusive-China's DeepSeek developing its own AI chip, sources say
Dicerna Pharma (DRNA) Appoints J. Kevin Buchi & Cynthia Smith to Board
August 17, 2018 5:59 AM EDTDicerna Pharmaceuticals, Inc. (NASDAQ: DRNA) today announced the appointments of J. Kevin Buchi, former chief executive officer of Cephalon, Inc., and TetraLogic Pharmaceuticals Corp., and Cynthia Smith, former chief commercial officer of ZS Pharma, Inc., to its board of directors. The appointments are effective immediately and increase the size of... More
